Consolidated Statement Of Income

ROHTO PHARMACEUTICAL CO.,LTD. - Filing #7295708

Concept 2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
Consolidated statement of income
Statement of income
Net sales
40,386,000,000 JPY
8,092,000,000 JPY
83,294,000,000 JPY
1,713,000,000 JPY
142,673,000,000 JPY
10,899,000,000 JPY
139,082,000,000 JPY
144,387,000,000 JPY
-5,304,000,000 JPY
9,607,000,000 JPY
36,497,000,000 JPY
77,952,000,000 JPY
7,091,000,000 JPY
132,585,000,000 JPY
127,869,000,000 JPY
-4,715,000,000 JPY
1,435,000,000 JPY
131,150,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
58,000,000 JPY
86,000,000 JPY
Cost of sales
60,574,000,000 JPY
53,909,000,000 JPY
Operating expenses
Selling, general and administrative expenses
60,716,000,000 JPY
52,993,000,000 JPY
Provision of allowance for doubtful accounts
-5,000,000 JPY
48,000,000 JPY
Operating expenses
Other operating expenses
Operating expenses
Operating expenses
Ordinary profit (loss)
18,590,000,000 JPY
22,678,000,000 JPY
Gross profit (loss)
78,507,000,000 JPY
73,960,000,000 JPY
Operating profit (loss)
6,037,000,000 JPY
538,000,000 JPY
9,872,000,000 JPY
145,000,000 JPY
17,108,000,000 JPY
659,000,000 JPY
17,791,000,000 JPY
17,254,000,000 JPY
536,000,000 JPY
564,000,000 JPY
5,847,000,000 JPY
13,233,000,000 JPY
881,000,000 JPY
20,659,000,000 JPY
20,966,000,000 JPY
307,000,000 JPY
130,000,000 JPY
20,528,000,000 JPY
General and administrative expenses
Net sales
Non-operating income
Interest income
708,000,000 JPY
671,000,000 JPY
Dividend income
307,000,000 JPY
268,000,000 JPY
Other
399,000,000 JPY
694,000,000 JPY
Non-operating income
1,473,000,000 JPY
2,187,000,000 JPY
Extraordinary income
787,000,000 JPY
JPY
Cost of sales
Selling, general and administrative expenses
Advertising expenses
18,009,000,000 JPY
15,977,000,000 JPY
Extraordinary losses
801,000,000 JPY
134,000,000 JPY
Impairment losses
16,000,000 JPY
JPY
Non-operating expenses
Interest expenses
128,000,000 JPY
109,000,000 JPY
Other
179,000,000 JPY
262,000,000 JPY
Non-operating expenses
674,000,000 JPY
476,000,000 JPY
Profit (loss) before income taxes
18,576,000,000 JPY
22,544,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
748,000,000 JPY
JPY
Extraordinary losses
Income taxes
5,766,000,000 JPY
5,719,000,000 JPY
Profit (loss)
12,809,000,000 JPY
16,824,000,000 JPY
Profit (loss) attributable to non-controlling interests
-111,000,000 JPY
229,000,000 JPY
Profit (loss) attributable to owners of parent
12,921,000,000 JPY
16,594,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
206,000,000 JPY
2,360,000,000 JPY
Foreign currency translation adjustment
6,135,000,000 JPY
7,360,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
0 JPY
1,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-18,000,000 JPY
-17,000,000 JPY
Other comprehensive income
6,323,000,000 JPY
9,705,000,000 JPY
Profit attributable to
Comprehensive income
19,133,000,000 JPY
26,530,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
19,210,000,000 JPY
26,176,000,000 JPY
Comprehensive income attributable to non-controlling interests
-77,000,000 JPY
353,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.